Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Robotic Surgery Consumables Market Worth USD 12.3 Billion to 2031 - Exclusive…
The global robotic surgery consumables market has witnessed remarkable growth driven by advancements in minimally invasive surgical techniques and the increasing adoption of robotic-assisted surgeries. These consumables encompass various instruments and accessories utilized in robotic surgical procedures, including surgical staplers, scalpels, sutures, and electrosurgical tools. The global robotic surgery consumables market has witnessed remarkable growth driven by advancements in minimally...
PR Newswire
23/05/2024
Infant Milk Formula Market Poised for 13.5% CAGR Surge, Targeting $22.35 Billion…
Since milk is a key nutritional choice for infants, the market for baby milk formula is growing at a remarkable pace. For those moms who are hesitant to breastfeed, milk formula is the only alternative. Milk formula supplies all of the nutrients the infant needs to stay healthy. Since milk is a key nutritional choice for infants, the market for baby milk formula is growing at a remarkable pace. For those moms who are hesitant to breastfeed, milk formula is the only alternative. Milk formula...
PR Newswire
23/05/2024
Precision Diagnostics Market Size to Hit USD 196.45 Bn by 2031: Coherent Market…
Market Dynamics: Market Dynamics : Rising prevalence of chronic and infectious diseases globally is expected to drive growth of the precision diagnostics market during the forecast period. According to WHO, chronic diseases accounted for approximately 60% of the 57 million global deaths in 2008, and chronic disease mortality is projected to rise by 15% globally between 2010 and 2020. In addition, advancements in genomic technologies have enabled development of precision diagnostics tools to...
PR Newswire
23/05/2024
Global Ambulatory Surgical Centers Market is Projected to Boost at a Moderate…
Key Takeaways from the Ambulatory Surgical Centers Market Report Key Takeaways from the Ambulatory Surgical Centers Market Report To read more about the latest highlights related to the ambulatory surgical centers market, get a snapshot of the key highlights entailed in theGlobal Ambulatory Surgical Centers Market Report Ambulatory Surgical Centers Overview Ambulatory Surgical Centers (ASCs) represent a pivotal evolution in healthcare delivery, providing specialized surgical...
PR Newswire
23/05/2024
D-dimer Testing Market to Reach $2.2 Billion Globally by 2032 at 5.1% CAGR…
Request Sample of the Report on D-dimer Testing Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/A298270 Request Sample of the Report on D-dimer Testing Market Forecast 2032 - https://www.alliedmarketresearch.com/request-sample/A298270 Prime Determinants of Growth The increasing prevalence of thrombotic disorders, rising demand for point-of-care D-dimer testing, and the emergence of aptamers as an alternative to antibodies are the factors expected to...
PR Newswire
23/05/2024
Nyxoah Announces Pricing of Offering
REGULATED INFORMATION INSIDE INFORMATIONNyxoah Announces Pricing of OfferingMont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the pricing of an underwritten public offering in the United States, which includes shares sold in a private...
Nasdaq GlobeNewswire
23/05/2024
Vistin Pharma ASA: Minutes from the annual general meeting 2024
Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the call for the annual general meeting, including the proposal to distribute a dividend of total NOK 1 per share, to be paid partly in June (NOK 0.5) and November (NOK 0.5).For the June dividend of NOK 0.5 per share, the shares will be traded excluding the right (ex-date) on the 5 thof June, with payment date on or...
Nasdaq GlobeNewswire
23/05/2024
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for…
/nab-paclitaxel) as a first line therapy for patients with pancreatic ductal adenocarcinoma (PDAC). Previously, the FDA granted orphan drug designation to VCN-01 for treatment of PDAC. “The FDA's decision to grant FTD to VCN-01 highlights the urgent need for new treatment options for PDAC, which accounts for the 4 thhighest cause of cancer-associated deaths in the US and Europe,” said Steven A. Shallcross, Chief Executive Officer of Theriva Biologics. “VIRAGE, our Phase 2b trial evaluating...
Nasdaq GlobeNewswire
23/05/2024
Taro Shareholders Approve Merger with Sun Pharma
Uday Baldota, Chief Executive Officer of Taro, said, "Throughout our fifteen-year relationship with Sun Pharma, Taro has benefited from their global scale and resources. This merger will further enable us to compete effectively in our products and markets." Uday Baldota, Chief Executive Officer of Taro, said, "Throughout our fifteen-year relationship with Sun Pharma, Taro has benefited from their global scale and resources. This merger will further enable us to compete effectively…
PR Newswire
23/05/2024
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year…
Link to today's analyst teach-in event Link to today's analyst teach-in event Webinar Registration - Zoom About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to...
PR Newswire
23/05/2024
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9…
PRESS RELEASE Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of action for the degradation of BRD9 – completely differentiated from cereblon- or VHL-based PROTACsAmphista's bifunctional BRD9 degraders selectively induce BRD9 to DCAF16 proximity and serve as molecular glues, leading to strong and rapid degradation of BRD9Discovery further underscores...
Nasdaq GlobeNewswire
23/05/2024
Disclosure of voting rights at AGM in Vistin Pharma ASA
In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 5 576 864 shares in the Company at the AGM, corresponding to 12.58% of the total number of votes and shares in the Company. Together with the 12 575 000 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 18 151 864 votes at the AGM, corresponding to a total of...
Nasdaq GlobeNewswire
23/05/2024
NTC Ophthalmics lberica: Young ophthalmologists square in Zahara Los Atunes
Pedro Zorita, General Manager of NTC in Spain, discloses the aim of the event: "We set up this work meeting to contribute to the professional career of the participants. NTC's vocation towards R&D and evidence-based medicine is embodied in our concrete and proactive approach, which always inspires us." Pedro Zorita, General Manager of NTC inSpain, discloses the aim of the event: "We set up this work meeting to contribute to the professional career of the participants. NTC's…
PR Newswire
23/05/2024
New report from Access to Medicine Foundation shows what pharma companies can do…
New report from the Access to Medicine Foundation tracks five such projects across the pipelines of GSK, F2G, Innoviva, Venatorx (gepotidacin , olorofim, zoliflodacin and cefepime-taniborbactam, respectively) and Pfizer's recently approved aztreonam-avibactam (Emblaveo®). Collectively, these projects could save at least 160,000 lives annually by providing much-needed medicines to treat drug-resistant gonorrhoea, urinary tract infections, intra-abdominal infections, respiratory infections, and…
PR Newswire
23/05/2024
Hypercholesterolemia Market is Predicted to Exhibit Remarkable Growth by 2034…
Key Takeaways from the Hypercholesterolemia Market Report Key Takeaways from the Hypercholesterolemia Market Report Discover which therapies are expected to grab the major hypercholesterolemia market share @Hypercholesterolemia Market Report Hypercholesterolemia Overview Hypercholesterolemia is marked by abnormally high cholesterol levels in the bloodstream. Cholesterol, a fatty substance, is both produced internally and sourced from certain foods like egg yolks, meat, and...
PR Newswire
23/05/2024
Hisense Wins Red Dot Award 2024 and iF Design Award 2024 for the ERF6A66 Solar…
The Hisense ERF6A66 Remote Control is compatible with Hisense UX, U7 and U8 TVs in the European and Oceanian markets and adopts a sleek and geometric design elevated by its concise shape and ergonomic hand-feeling. Created to complement any home lifestyle, the solar charging panel is strategically positioned on the top surface, aligning with user placement habits and optimizing solar area efficiency. The seamless integration of the solar area and the remote's control main body not only enhances…
PR Newswire
23/05/2024
THE LEGO GROUP CELEBRATES CHILDREN'S UNIQUE CURIOSITY ABOUT THE COSMOS BY ASKING…
A new global study1 by the LEGO Group finds that 86 percent of kids aged four to 14 are interested in finding new planets, stars and galaxies, and 77 percent want to travel to space. Additionally, more than 3 in 5 (68 percent) children believe there are aliens in space, and 64 percent say they would want to meet one. A new global study 1by the LEGO Group finds that 86 percent of kids aged four to 14 are interested in finding new planets, stars and galaxies, and 77 percent want to travel to…
PR Newswire
23/05/2024
Degenerative Disc Disease Treatment Market to Reach $46.2 Billion Globally by…
Request Sample of the Report on Degenerative Disc Disease Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/A269439 Request Sample of the Report on Degenerative Disc Disease Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/A269439 Prime Determinants of Growth The increasing prevalence of degenerative disc disease (DDD) among the aging population, growing awareness about spine health and available treatment options, and the...
PR Newswire
23/05/2024
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick…
The benefits of the SCOPEYE 3D Micro Surgery Solution are manifold. With high-resolution 3D optics, surgeons gain unparalleled visual clarity and depth perception, enhancing their precision and accuracy during procedures. Additionally, the solution offers significant cost efficiencies, maximised ergonomic comfort, and advanced features such as 3D recording and training capabilities, further enhancing patient care and surgical outcomes. The benefits of the SCOPEYE 3D Micro Surgery Solution are…
PR Newswire
23/05/2024
LiuGong Makes Its Debut at CSPI-EXPO 2024
On the first day of the exhibition, LiuGong held the Electric Product launch at its booth. Industry media from Japan and Xinhua News Agency conducted an exclusive interview with Zeng Guang'an, Chairman and CEO of LiuGong. "Since embarking on the development of electric technology in 2014, LiuGong has made significant achievements in the field of electric intelligence over a decade of relentless pursuit and innovation. LiuGong's electric equipment has been successfully promoted in China…
PR Newswire
23/05/2024
Disclosure of voting rights for Chair of the Board
Hans Peter Bøhn is chair of PCI Biotech's board of directors and shall open the annual general meeting of the Company on 24 May 2024. Mr. Bøhn holds 123,662 shares, representing 0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 4,288,185 additional shares. In total, Mr. Bøhn will represent and vote for 11.8 percent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of...
Nasdaq GlobeNewswire
23/05/2024
ANNEMARIE BÖRLIND Leads the Way in China's Cosmetic Paradigm Shift with Vegan…
ANNEMARIE BÖRLIND is now seizing the opportunity to unveil a groundbreaking skincare line tailored to the demands of the modern, conscious consumer. ANNEMARIE BÖRLIND is now seizing the opportunity to unveil a groundbreaking skincare line tailored to the demands of the modern, conscious consumer. NatuCollagen is a pioneering skincare series that leverages plant-based collagen to provide a natural solution for maintaining youthful and radiant skin. Vegan collagen, the key ingredient and a...
PR Newswire
23/05/2024
Bionoxx to Highlight Innovative Strategy for Addressing Immune-Related Diseases…
Bionoxx research has discovered that cancer patients exhibit impaired neutrophil homeostatic dynamics in their peripheral blood, a condition that may significantly contribute to T cell dysfunction and suboptimal clinical outcomes in these individuals. BNX has pioneered the BNX-IFS, a novel technology aimed at identifying activated neutrophils linked to T cell homeostasis within circulating immune cells. Bionoxx has already received clearance of an Investigational New Drug (IND) application by…
PR Newswire
23/05/2024
Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human…
The study investigated the safety of H-Guard® in patients undergoing haemodialysis who are vulnerable to dialysis-induced immune activation. H-Guard® is flushed through the dialysis machine, coating all blood exposed surfaces prior to treatment. The study investigated the safety of H-Guard® in patients undergoing haemodialysis who are vulnerable to dialysis-induced immune activation. H-Guard® is flushed through the dialysis machine, coating all blood exposed surfaces prior to treatment...
PR Newswire
23/05/2024
Altri Comunicati
